284 related articles for article (PubMed ID: 16825015)
1. Advanced glycation end products in renal failure.
Thornalley PJ
J Ren Nutr; 2006 Jul; 16(3):178-84. PubMed ID: 16825015
[TBL] [Abstract][Full Text] [Related]
2. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
3. Highlights and hotspots of protein glycation in end-stage renal disease.
Thornalley PJ; Rabbani N
Semin Dial; 2009; 22(4):400-4. PubMed ID: 19708990
[TBL] [Abstract][Full Text] [Related]
4. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis and consequences of AGE formation in uraemia and its treatment.
Dawnay A; Millar DJ
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1081-94. PubMed ID: 9846890
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end product free adducts are cleared by dialysis.
Agalou S; Ahmed N; Thornalley PJ; Dawnay A
Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300
[TBL] [Abstract][Full Text] [Related]
7. Glycation free adduct accumulation in renal disease: the new AGE.
Thornalley PJ
Pediatr Nephrol; 2005 Nov; 20(11):1515-22. PubMed ID: 16133053
[TBL] [Abstract][Full Text] [Related]
8. An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients.
Schwenger V; Morath C; Schönfelder K; Klein W; Weigel K; Deppisch R; Henle T; Ritz E; Zeier M
Nephrol Dial Transplant; 2006 Feb; 21(2):383-8. PubMed ID: 16204288
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts (AGEs) as uremic toxins.
Schwenger V; Zeier M; Henle T; Ritz E
Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in renal failure: an overview.
Noordzij MJ; Lefrandt JD; Smit AJ
J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed N; Thornalley PJ
Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
Lapolla A; Flamini R; Lupo A; Aricò NC; Rugiu C; Reitano R; Tubaro M; Ragazzi E; Seraglia R; Traldi P
Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242
[TBL] [Abstract][Full Text] [Related]
15. Measurement of protein glycation, glycated peptides, and glycation free adducts.
Thornalley PJ
Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322
[TBL] [Abstract][Full Text] [Related]
16. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of markers of protein damage by glycation, oxidation, and nitration in peritoneal dialysis.
Rabbani N; Thornalley PJ
Perit Dial Int; 2009 Feb; 29 Suppl 2():S51-6. PubMed ID: 19270232
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review.
Arsov S; Graaff R; van Oeveren W; Stegmayr B; Sikole A; Rakhorst G; Smit AJ
Clin Chem Lab Med; 2014 Jan; 52(1):11-20. PubMed ID: 23612551
[TBL] [Abstract][Full Text] [Related]
19. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
20. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kanková K
Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
